Search Results - "Dienemann, H"

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma by Scherpereel, A, Astoul, P, Baas, P, Berghmans, T, Clayson, H, de Vuyst, P, Dienemann, H, Galateau-Salle, F, Hennequin, C, Hillerdal, G, Le Pechoux, C, Mutti, L, Pairon, J-C, Stahel, R, van Houtte, P, van Meerbeeck, J, Waller, D, Weder, W

“…Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a poor prognosis. In 2008, the European Respiratory Society/European…”
Get full text

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo by Gassler, N., Zhang, C., Wenger, T., Schnabel, P. A., Dienemann, H., Debatin, K. -M, Mattern, J., Herr, I.

Get full text

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role by Warth, A, Cortis, J, Soltermann, A, Meister, M, Budczies, J, Stenzinger, A, Goeppert, B, Thomas, M, Herth, F J F, Schirmacher, P, Schnabel, P A, Hoffmann, H, Dienemann, H, Muley, T, Weichert, W

“…Background: Uncontrolled proliferation is a hallmark of malignant tumour growth. Its prognostic role in non-small cell lung cancer (NSCLC) has been…”
Get full text

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer by Schneider, T., Sevko, A., Heussel, C. P., Umansky, L., Beckhove, P., Dienemann, H., Safi, S., Utikal, J., Hoffmann, H., Umansky, V.

“…Summary In recent years, percutaneous radiofrequency ablation (RFA) has been developed as a new tool in the treatment of non‐small‐cell lung cancer (NSCLC) in…”
Get full text

Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization by Becker, N, Motsch, E, Gross, M-L, Eigentopf, A, Heussel, C P, Dienemann, H, Schnabel, P A, Eichinger, M, Optazaite, D-E, Puderbach, M, Wielpütz, M, Kauczor, H-U, Tremper, J, Delorme, S

“…The German Lung Cancer Screening Intervention Trial (LUSI) is one of the European randomized trials investigating the efficacy of low-dose multislice computed…”
Get more information

Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum by Herth, F. J. F, Ernst, A, Eberhardt, R, Vilmann, P, Dienemann, H, Krasnik, M

“…Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) can sample enlarged mediastinal lymph nodes in patients with nonsmall cell lung…”
Get full text

Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round by Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Pilz, L., Eichinger, M., Optazaite, D.-E., Puderbach, M., Tremper, J., Delorme, S.

“…Purpose Low-dose multislice-CT (MSCT) detects many early-stage lung cancers with good prognosis, but whether it decreases lung cancer mortality and at which…”
Get full text

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases by Kahlert, C, Pecqueux, M, Halama, N, Dienemann, H, Muley, T, Pfannschmidt, J, Lasitschka, F, Klupp, F, Schmidt, T, Rahbari, N, Reissfelder, C, Kunz, C, Benner, A, Falk, C, Weitz, J, Koch, M

“…Background: Tumour-associated stroma has a critical role in tumour proliferation. Our aim was to determine a specific protein expression profile of stromal…”
Get full text

Management of chylothorax in adults: when is surgery indicated? by Zabeck, H, Muley, T, Dienemann, H, Hoffmann, H

“…The aim of this retrospective study was to analyze the etiology, management and outcome of patients with chylothorax and identify clinical parameters for…”
Get more information

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response by Dvornikov, D., Schneider, M. A., Ohse, S., Szczygieł, M., Titkova, I., Rosenblatt, M., Muley, T., Warth, A., Herth, F. J., Dienemann, H., Thomas, M., Timmer, J., Schilling, M., Busch, H., Boerries, M., Meister, M., Klingmüller, U.

“…In lung cancer a deregulation of Transforming Growth Factor-β (TGFβ) signaling has been observed. Yet, the impact of TGFβ in squamous cell carcinoma of the…”
Get full text

Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4 by Scherf, D B, Sarkisyan, N, Jacobsson, H, Claus, R, Bermejo, J L, Peil, B, Gu, L, Muley, T, Meister, M, Dienemann, H, Plass, C, Risch, A

“…Genome-wide association studies have highlighted three major lung cancer susceptibility regions at 15q25.1, 5p15.33 and 6p21.33. To gain insight into the…”
Get full text

Survival after pulmonary metastasectomy in patients with malignant melanoma by Schuhan, C, Muley, T, Dienemann, H, Pfannschmidt, J

“…Surgical resection is an important interdisciplinary treatment for pulmonary metastases of metastatic malignant melanoma. The purpose of this study was to…”
Get more information

Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients by Schneider, T, Puderbach, M, Kunz, J, Bischof, A, Giesel, F L, Dienemann, H, Herth, F J F, Schnabel, P A, Safi, S, Hoffmann, H, Heussel, C P

“…In recent years experience has been accumulated in percutaneous radiofrequency ablation (RFA) of lung malignancies in nonsurgical patients. In this study, we…”
Get more information

hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population by Wikman, H., Risch, A., Klimek, F., Schmezer, P., Spiegelhalder, B., Dienemann, H., Kayser, K., Schulz, V., Drings, P., Bartsch, H.

“…Oxidative damage is implicated in several chronic diseases including cancer. 8‐Hydroxyguanine (8‐oxoG) is one of the major promutagenic DNA lesions, which is…”
Get full text

26IN WHEN IS IT JUSTIFIED TO TREAT PULMONARY METASTASIS WITH LOCAL THERAPIES? WHICH ARE THE MOST FREQUENT METASTASES? by Pfannschmidt, J, Dienemann, H

Get full text

Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo by Gassler, N, Zhang, C, Wenger, T, Schnabel, P A, Dienemann, H, Debatin, K-M, Mattern, J, Herr, I

“…Chemotherapy for lung cancer not only has severe side effects but frequently also exhibits limited, if any clinical effectiveness. Dexamethasone (DEX) and…”
Get full text

Principles of surgical treatment in localized non-small cell lung cancer by Dienemann, H

“…Non-small cell cancer has become the leading cause of cancer-related deaths in women and men in the western hemisphere. Surgical resection remains the mainstay…”
Get full text

VATS lobectomy in stage I lung cancer: standard or experimental procedure by Dienemann, H, Hoffmann, H

“…Video-assisted thoracoscopic surgery (VATS) for lobectomy in stage I non-small cell lung cancer (NSCLC) was introduced in 1991 and has been accompanied by…”
Get more information

Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients by Pfannschmidt, J, Klode, J, Muley, T, Dienemann, H, Hoffmann, H

“…Pulmonary resection of metastatic soft tissue sarcomas is an accepted method of treatment. The purpose of this study was to determine the clinical course,…”
Get more information

898 Circulating MicroRNAs Associated With Early Relapse in Early-stage NSCLC by Kuner, R, Kaduthanam, S, Gade, S, Brase, J.C, Johannes, M, Sultmann, H, Muley, T, Meister, M, Herth, F.J, Dienemann, H

Get full text